The University Hospital of Basel, in Basel, is one of the five university hospitals of Switzerland. Since 1842 it is located in a former palace, the Markgräflerhof. USB brings together 50 clinics, units and institutes all working together in an interdisciplinary manner and employs a staff of about 5000.

There are 773 beds in University Hospital Basel, Division of Endocrinology, Diabetes and Metabolism.

During the past decade, University Hospital Basel, Division of Endocrinology, Diabetes and Metabolism conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital Basel, Division of Endocrinology, Diabetes and Metabolism" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital Basel, Division of Endocrinology, Diabetes and Metabolism" are "Postprandial Hypoglycemia" (2 trials). Many other conditions were trialed in "University Hospital Basel, Division of Endocrinology, Diabetes and Metabolism" in a lesser frequency.

Most popular intervention types in "University Hospital Basel, Division of Endocrinology, Diabetes and Metabolism" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Canakinumab" (1 trials), "Empagliflozin (Jardiance®;" (1 trials), "Placebo (0.9% NaCl)" (1 trials) and "Placebo Control Intervention" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital Basel, Division of Endocrinology, Diabetes and Metabolism" are 2 trials for "All" genders.

Currently, there are NaN active trials in "University Hospital Basel, Division of Endocrinology, Diabetes and Metabolism". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in University Hospital Basel, Division of Endocrinology, Diabetes and Metabolism, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital Basel, Division of Endocrinology, Diabetes and Metabolism, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".